ABCA1 and neoplasm: Finally, to determine whether ABCA1 can be an effective target for the treatment of IDHWT GBMs, we performed a lovastatin treatment experiment in the orthotopic GL261IDH1-WT-Luc model and showed that this modulation of immune metabolism can significantly control tumor progression (Figures 7K–M).